Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions

In this Regenerative Medicine research article, discover how dose, demand and lot size affects the cost-effectiveness of cell therapy processing.

Go to the profile of Regenerative Medicine
Oct 02, 2017
Upvote 0 Comment

Allogeneic stem cells are showing clinical promise in several therapeutic indications, with regional approvals for graft-versus-host disease and osteoarthritis. In this research article,learn more about a decisional tool to investigate the impact of commercial doses, demands and lot sizes on the cost–effectiveness of scalable, single-use downstream processing and fill finish technologies for cell therapies.

Hassan S, Simaria AS, Varadaraju H, Gupta S, Warren K, Farid SS. Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions. Regen. Med. 10(5), 591–609 (2015)

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (, where you can find the aims and scope of the journal and details of our international editorial board.
96 Contributions
235 Following

No comments yet.